Zetia/Zocor combo is Vytorin
Executive Summary
Merck and Schering-Plough choose Vytorin as the brand name for the fixed-dose ezetimibe/simvastatin combination. Companies filed for approval of Zetia/Zocor for cholesterol reduction in July 2003; the user fee deadline is Sept. 24, 2004. Zetia was approved in 2002 for use as monotherapy and in combination with Zocor (1"The Pink Sheet" Nov. 4, 2002, p. 5)...
Merck and Schering-Plough choose Vytorin as the brand name for the fixed-dose ezetimibe/simvastatin combination. Companies filed for approval of Zetia / Zocor for cholesterol reduction in July 2003; the user fee deadline is Sept. 24, 2004. Zetia was approved in 2002 for use as monotherapy and in combination with Zocor (1 (Also see "Schering/Merck Zetia Clears FDA; Price Favors Combo With Low-Dose Zocor" - Pink Sheet, 4 Nov, 2002.), p. 5).... |